EVALUATION OF HEALTHCARE PROFESSIONALS' EXPERIENCES AND ATTITUDES TOWARDS ADVERSE DRUG REACTIONS (ADRS) REPORTING AT RSUP DR. HASAN SADIKIN BANDUNG
Post-marketing surveillance of drug safety is a continuous process within the pharmacovigilance system. One form of implementing pharmacovigilance is the reporting of adverse drug reactions (ADRs) by healthcare professionals. However, the number of ADR reports in Indonesia as an important indi...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/74005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Post-marketing surveillance of drug safety is a continuous process within the pharmacovigilance
system. One form of implementing pharmacovigilance is the reporting of adverse drug reactions
(ADRs) by healthcare professionals. However, the number of ADR reports in Indonesia as an
important indicator of success of the pharmacovigilance system is still very low, which is less then
10.000 reports per year. This study aims to assess the experiences, motivations, and barriers faced
by healthcare professionals in reporting ADRs. The study was conducted using an observational
cross-sectional method with an online questionnaire filled out by 92 respondents. The results
showed that the experience of reporting ADRs among healthcare professionals is still low. Although
64,13% (n = 59) of respondents stated that they had received ADR reports directly from patients,
only 42,39% (n = 39) of respondents reported ADRs. The highest motivation for reporting ADRs is
the occurrence of severe or serious ADRs and a strong suspicion towards causal relationship
between drug and side effects. Healthcare professionals tend not to report ADRs when there is
uncertainty about the ADRs experienced by the patient or when the patient’s ADRs have been
resolved. Furthermore, there were significant differences in the types and conditions of barriers
between pharmacists and nurses in reporting ADRs (p = 0,011).
|
---|